Delete search term

To content

Main navigation

Zurich University
of Applied Sciences

Service navigation

AIT India 2026/27: CelluloseHeal

Meet Noël Marc Speck, one of the ten Switzerland-based participants in the 2026/27 edition of the Academia-Industry Training India program.

Interview with Noël Marc Speck

“My research addresses the unmet need for an advanced, bioactive, and sustainable wound dressing that stimulates chronic wound healing, a silent epidemic that affects up to 4 % of the global population.”

What problem does your startup solve, and why is it important to you personally?

My research addresses the unmet need for an advanced, bioactive, and sustainable wound dressing that stimulates chronic wound healing, a silent epidemic that affects up to 4 % of the global population. I realized that not only patients are affected by chronic wounds but that it also has an impact on doctors, hospitals, family members. I want to contribute to a better society, and with my skills and passions, this is one way I want to do it.

What inspired you to become a sciencepreneur, and what has been your biggest “aha!” moment so far?

I have always been fascinated by how scientific findings could make our world a better place. At the same time, I enjoy creating tangible things, especially if it creates a real-life impact. I am always most interested in how research transcends pure academic purposes and results in impactful ventures. My biggest “aha!” moment has been that convincing the patients and wound physicians that my solution works is equally important as developing the most potent wound dressing.

What unique perspective does your academic background bring to your startup?

Thanks to my background in mechanical and biomedical engineering, I work at the interface of biology and engineering and can navigate the perspectives and requirements of both disciplines well. Thus, for every materials engineering step, I consider how this might affect the biological response. Moreover, as I conduct research in an interdisciplinary laboratory, I am continuously pushed to learn about complex topics from unfamiliar fields which helps me to stay agile and move outside of my comfort zone.

What’s one surprising lesson you’ve learned since launching your startup?

I realized that very frequently in scientific literature, promising results reporting accelerated chronic wound healing are almost impossible to translate into a commercial product. It is either because the fabrication processes are not scalable or the raw materials are expensive or difficult to source. I have learnt that it is not only challenging to find a mechanism that accelerates wound healing but also one that is cost-efficient and scalable.

If you could host a dinner with three innovators (past or present), who would they be and why?

I would invite Daniela Marino (CEO of Cutiss), Robert Langer (MIT professor and often considered the father of tissue engineering), and Alexander Fleming (inventor of penicillin). I think we would have an animated discussion about biotech, engineering, and Medicine, and about how their innovations have or will shape the world. I would be curious to know what motivated them to go down those roads and if they knew that their work would be so impactful.

Privacy Settings

Here we show you which services may run on our website. You decide for yourself which services we may use. You can find more information in our privacy notice.

Our website needs these cookies so that everything works properly. These cookies are created automatically when you are active on the site – for example, when you change privacy settings or fill in forms. You can block these cookies in your browser or set it to warn you about them, but some parts of the website will then no longer display correctly. These cookies do not store any of your personal data.

These services allow us to see how our website is used, but we do not know who you are. By activating these services, you help us make the website better for everyone.